Product Recalls in New Jersey

Product recalls affecting New Jersey — including food, drugs, consumer products, medical devices, and vehicles distributed to New Jersey. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,814 recalls have been distributed to New Jersey in the last 12 months.

53,621 total recalls
2,814 in last 12 months

Showing 1044110460 of 13,536 recalls

DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Fentanyl 7 Recalled by The Compounding Pharmacy of America Due to Lack of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Tri-Mix (25/2.5/10) Injectable Recalled by The Compounding Pharmacy of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Sermorelin/GHRP6 1000/1000 mcg/ml Injection Recalled by The Compounding...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Folic Acid 5 mg/ml Injection Recalled by The Compounding Pharmacy of America...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Sermorelin 300 mcg/ml + GHRP-2 300 mcg/ml Injection Recalled by The...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: LIPO-EXTREME Injectable Recalled by The Compounding Pharmacy of America Due...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Nandrolone Decanoate 200 mg/ml Injection Recalled by The Compounding...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Oxytocin 100 units/ml Injection Recalled by The Compounding Pharmacy of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Zonisamide capsules Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets Recalled by American Health Packaging Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Famotidine tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets Recalled by American Health Packaging Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Clarithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund